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ABSTRACT
Graft-versus-host disease (GVHD) can be induced in lethally irradiated mice after allogeneic bone marrow
transplantation between major histocompatibility complex–matched strains expressing multiple minor histo-
compatibility antigen differences. In the B63 BALB.B irradiation model, both CD4 and CD8 donor T cells
have the capacity to mediate lethal GVHD. Previously, CDR3-size spectratyping was used to analyze these
T-cell responses at a single early time point (day 5) after transplantation and revealed clonal or oligoclonal
expansions of the V 2, 4, and 6 to 14 families for the CD4 response and of the V 4, 6, 8 to 11, and 14 families
for the B6 CD8 response. Appropriate positive selection of these T-cell receptor V-skewed CD4 and
CD8 T-cell subsets and their subsequent transfer into lethally irradiated BALB.B recipients resulted in fatal
GVHD induction. In contrast, BALB.B mice transplanted with nonskewed V CD4 T cells survived, with
minimal symptoms of GVHD. This study was undertaken to investigate the evolution of the donor/antihost
minor histocompatibility antigen T-cell repertoire responses throughout the course of GVHD development.
The results indicated that a number of V families were consistently involved throughout the course of
GVHD, whereas some V families exhibited skewed expansions only in either the early or late stages of
disease. In addition, sequence analysis of relevant representative skewed CDR3 bands from the CD4 V 11
and the CD8 V 14 families, both of which exhibited strong consistent responses, demonstrated increased
use of the J 2.5 and J 2.4 segments, respectively, thus identifying the T-cell receptor specificities involved.
© 2004 American Society for Blood and Marrow Transplantation
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CNTRODUCTION
Graft-versus-host disease (GVHD) is a major
omplication of allogeneic hematopoietic cell trans-
lantation (HCT) [1,2], an effective approach for the
reatment of several hematologic malignancies [3].
ature alloreactive T cells within the donor stem cell
noculum mediate GVHD [4]. For most cases in
hich allogeneic transplantations are performed be-
ween HLA-matched siblings or HLA-matched unre-
ated donors, the alloresponse is directed to minor
istocompatibility antigens (miHA) expressed on host
issues [5-7]. The miHA are endogenously or exog- r
24nously processed self-protein degradation products
hat can be presented in association with either major
istocompatibility complex (MHC) class I or class II
olecules on host parenchymal and antigen-present-
ng cells, resulting in stimulation of donor CD4 and
D8 T cells, respectively [5-7]. Allogeneic donor T
ells with the same MHC molecules can thus recog-
ize miHA that they themselves do not express.
In experimental murine allogeneic bone marrow
ransplantation models using lethally irradiated
HC-matched miHA-disparate recipients, donor
D8 T cells tend to dominate the lethal GVHD
esponse and can function either independently or
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CD4 and CD8 TCR V Repertoires during GVHD
Bependently on the cytokine help provided by anti-
iHA speciﬁc CD4 T cells [8,9]. However, in some
ases, CD4 T cells alone can also mediate lethal
VHD [8-11]. The GVHD potential of CD4 T
ells is also observed in the MHC-matched, miHA-
isparate C57BL/6 (B6) 3 C.B10-H2b (BALB.B) ir-
adiation model, on which we have been focusing
xtensive investigation [9,12-14]. In earlier experi-
ents to analyze the repertoire of both CD4 and
D8 T cells involved in the early development of
VHD, lethally irradiated BALB.B mice were trans-
lanted with B6 T cells, and miHA-reactive T-cell
lasts were collected 5 days later from the thoracic
uct lymphocyte pool [14]. The cells were then exam-
ned by polymerase chain reaction (PCR)–based T-
ell receptor (TCR) V CDR3-size spectratyping
nalysis, which is highly sensitive to differential ex-
ansions within the T-cell population. The spectra-
ype histogram proﬁles of control nonreactive T-cell
 family populations exhibited a Gaussian distribu-
ion of CDR3-size peaks [14,15]. Clonal or oligo-
lonal expansions of alloreactive T cells within a given
 family were thus detected by a signiﬁcantly in-
reased intensity of 1 or more histogram peaks, as
ompared with that of the unstimulated control pop-
lation. This initial spectratype analysis of the B6
nti-BALB.B CD4 T-cell response indicated that
he V 2, 4, and 6 to 14 families were potentially
nvolved in GVHD development [14]. Similarly, the
D8 T-cell antihost miHA response seemed to in-
olve the TCR V 1, 4, 6, 8 to 11, and 14 families [16].
ata supporting these observations came from exper-
ments in which spectratype-identiﬁed V families of
ither B6 CD4 or CD8 T-cell subsets were se-
ected, enriched for in donor inoculum, and injected
nto lethally irradiated BALB.B recipients, where they
etained the capacity to induce fatal GVHD [14,16].
n contrast, as demonstrated in the case of BALB.B
ice transplanted with B6 CD4 T cells, those recip-
ents of V families not implicated by the spectratype
nalysis survived with minimal signs of GVHD [14].
Noting that GVHD is a dynamic, evolving process
1,2], we have extended our studies to examine the
onor anti-miHA T-cell repertoire response during
he course of the disease to better understand its scope
nd consistency. For this evaluation, lethally irradi-
ted BALB.B recipients were transplanted with T
ell–depleted B6 bone marrow cells along with either
ost-presensitized B6 CD4 or CD8 T cells to max-
mize their GVHD-inducing potential. Spleens from
ransplanted mice were then harvested at various time
oints, and spectratyping was performed to character-
ze the TCR V repertoire. The results demonstrated
early consistent CDR3 size skewings within most
reviously identiﬁed V families (V 2, 6-8.1, 10, 11,
3, and 14 for CD4; V 8.2, 8.3, 12-14, and 16 for
D8) throughout the course of GVHD development. (
B&MTtandard histologic staining of the lingual epithelium
rom these mice exhibited lymphocyte inﬁltration and
vidence of epithelial apoptosis, conﬁrming the pres-
nce of GVHD immunopathology. Seven additional
 families for CD4 (V 3, 8.2, 8.3, 9, 12, 15, and 16)
nd 12 V families for CD8 (V 1, 3-7, 8.1, 9-11, 18,
nd 20) exhibited only transient T-cell involvement at
ither earlier or later time points after transplantation,
ut not both. Three remaining V families for CD4
V 1, 4, and 5) and 2 for CD8 (V 2 and 15) did not
xhibit CDR3-size skewing at any time point during
he course of GVHD. Finally, depletion of the more
onsistently and early onset–skewed CD4 V families
rom the donor T-cell inoculum seemed to change the
inetics of the anti-miHA responses within the re-
aining CD4 V families.
ATERIALS AND METHODS
ice
C57BL/6By (B6) and C.B10-H2b/LiMcdJ
BALB.B) mice, both of the H2b haplotype, were
urchased from and/or raised in our breeding colony
rom breeder pairs provided by The Jackson Labora-
ory (Bar Harbor, ME). C3H/HeJCr (C3H) mice of
he H2k haplotype were purchased from The Freder-
ck Cancer Research & Development Center of the
ational Cancer Institute (Frederick, MD). For all
xperiments, sex-matched mice were used as donors
nd recipients between the ages of 7 and 16 weeks.
ice were kept in a pathogen-free environment in
utoclaved microisolator cages and were provided
ith autoclaved water and food ad libitum.
edia
Phosphate-buffered saline (PBS; BioWhittaker,
alkerville, MI) supplemented with 0.1% bovine se-
um albumin (BSA; Sigma, St. Louis, MO) was used
or all in vitro manipulations of lymphocytes.
rradiation
Recipient mice received a lethal dose of whole-
ody irradiation (10 Gy) from a Gammacell cesium
37 source (Atomic Energy of Canada, Kanata, On-
ario, Canada) at a dose rate of 1.16 Gy/min.
onoclonal Antibodies
Ascites ﬂuid for anti-Thy1.2 (J1j; rat immuno-
lobulin [Ig]M [17]), anti-CD4 (RL172; rat IgG [18]),
nd anti-CD8 (3.168; rat IgM [19]) monoclonal anti-
odies (mAb) were used for cell preparations. Afﬁnity-
uriﬁed goat anti-mouse IgG (whole molecule) anti-
ody was purchased from Cappel-Organon Teknika
West Chester, PA). Fluorescein isothiocyanate
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2FITC)–conjugated anti-V mAbs were purchased
rom PharMingen (San Diego, CA).
reparation of Donor Cells
T cell–enriched donor cells were prepared from
ooled spleen and lymph node cell suspensions from
6 mice that were presensitized and boosted with
ALB.B spleen cells (1.5  107 cells; intraperitoneal
njection; 2.5 weeks apart). The cells were initially
esuspended in Gey’s balanced salt solution contain-
ng 0.7% NH4Cl to remove red blood cells and were
ltered through a cell strainer to remove dead cells. B
ells were removed by panning the cell suspension
ver goat anti-mouse IgG–coated plastic Petri dishes
or 1 hour at 4°C. The nonadherent (T cell–enriched)
ells were harvested, and the population was 85% to
0% CD3, as determined by ﬂow cytometry. For
nalysis of the CD8 subset repertoire, CD4 T cells
ere depleted by incubation with RL172 mAb (1:100
ilution of ascites ﬂuid) and guinea pig complement
1:30 dilution; Rockland, Gilbertsville, PA) in 6 mL of
BS and 0.1% BSA at 37°C for 50 minutes. For
D4 subset repertoire analysis, CD8 T cells were
epleted by incubation with 3.168 mAb in the pres-
nce of complement. Anti–T cell–depleted bone mar-
ow (ATBM) was prepared by ﬁrst ﬂushing cells from
he femurs and tibias of B6 donor mice with PBS and
.1% BSA, followed by incubation with J1j mAb (1:
00 dilution) and complement for 50 minutes. Posi-
ively selected cells were washed twice and resus-
ended in PBS for intravenous injection. Separation
f V-skewed CD4 T cells was performed as previ-
usly described [14].
reparation of RNA and Complementary DNA
Total cellular RNA was prepared as previously
escribed [16] from splenic T cells homogenized in 1
L of Ultraspec (Biotecx Laboratories, Houston,
X), separating cellular DNA and protein by the
ddition of a 1:5 volume of chloroform, vortexing for
seconds, and centrifuging at 12500 rpm for 15 min-
tes. The aqueous phase was transferred to a clean
ppendorf tube, and RNA was precipitated at 4°C by
dding an equal volume of isopropanol and centrifug-
ng at 12500 rpm for 15 minutes. The pellet was
ashed with 75% ethanol in diethylpyrocarbonate
DEPC)–treated water and centrifuged again, and the
NA pellet was resuspended in 25 L of DEPC
ater, heated to 55°C to 65°C for 10 minutes, and
tored at 20°C. Recovery of RNA was determined
y spectrophotometry. The poly(A) portion of the
otal RNA was converted into complementary DNA
cDNA) by using oligo(dT) as a primer for reverse
ranscription. Total RNA (2 g) in a volume of 9.5 L
as heated to 70°C to 80°C, centrifuged for a few
econds, and placed on ice. Master mix (17.5 L) s
26ontaining 1 L of RNasin (40 U/L); 6 L of 5
aloney murine leukemia virus reverse transcriptase
eaction buffer; 3 L of oligo(dT) primer (20 mmol/
); 1.5 L of deoxynucleotide triphosphates (dA, G,
, and T, 25 mmol/L each); and 3 L of Maloney
urine leukemia virus reverse transcriptase (300 U/L)
as incubated at 37°C for 1.5 hours to synthesize cDNA.
ll reagents were purchased from Promega (Madison,
I). The reaction mixture was heated to 95°C for 3
inutes, and the cDNA was stored at 20°C.
CR Amplification of cDNA and CDR3-Size
pectratyping
PCR was performed by using a ﬂuorescent-labeled
onstant primer (Cb) and a V primer speciﬁc for
ach V family to be analyzed [20]. Cb primers were
uorescently labeled and purchased from PE-Applied
iosystems (Foster City, CA). All the primers used
ave been previously described [14,16,21]. Five mi-
roliters of 10 Taq Polymerase Buffer B (Promega)
as added to 5 L of cDNA plus 2 L of MgCl2 (25
mol/L); 4 L of dNTPS dA, G, C, and T (25
mol/L each); 2.5 L of V sense primer (20 mol/
); 4 L of Cb-labeled antisense primer (12 mol/
); 28 L of DEPC water; and 1 L of Taq polymer-
se (2-5 U/L; Promega). Thirty-ﬁve cycles of
mpliﬁcation were performed, and on completion of
CR, the ﬂuorescently labeled PCR products were
un on a sequencing gel and analyzed by the Geno-
yper Genescan software program (PE-Applied Bio-
ystems). In an effort to standardize the representation
f the data, all V family histogram peaks were num-
ered 1 to 6 from the shorter to the longer product
izes within the respective spectratype.
uantitation of CDR3-Size Usage
To determine the signiﬁcance of the spectratype
ata for each V family, spectratype analysis was re-
eated 3 times for normal B6 control CD4 and
D8 splenic T cells and twice for the experimental
roups. On days 7, 11, 15, 33, and 40, splenic CD4
cells were isolated and pooled from 3 to 5 mice, and
DR3-size spectratype analysis was performed. These
xperimental spectratypes were compared with con-
rol naive splenic B6 CD4 T-cell spectratypes, which
ere generated from 3 sets of 3 mice each. The areas
nder the corresponding peaks were averaged for each
 histogram. A band was considered to be skewed if
he mean area under the peak was greater than the
ean  3 the SD of the corresponding normal
ontrol peak [14].
NA Sequencing
The PCR products corresponding to the speciﬁc
kewed CD4 V 11 and CD8 V 14 TCR V
pectratype bands were eluted from the sequencing
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CD4 and CD8 TCR V Repertoires during GVHD
Bels and reampliﬁed by using the V 11 and V 14
rimers, respectively. The reampliﬁed DNA was run
n a 1.5% agarose gel, the bands of interest were
xcised, and the DNA was puriﬁed by using a QIA-
uick Gel Extraction Kit (Qiagen, Valencia, CA). The
uriﬁed DNA was cloned into the pGEM-T vector
ystem (Promega). This approach produced a spec-
rum of clones representative of all the band PCR
roducts and their relative frequencies. Between 10
nd 20 colonies containing the inserted fragments
ere randomly selected and sequenced by using a Big
ye Cycle Sequencing Kit (PE-Applied Biosystems).
istologic Staining
Routine histologic staining of the lingual epithe-
ium with hematoxylin and eosin dyes was performed
s previously described and graded on a semiquanti-
ative scale of epithelial lymphoid inﬁltration and
poptotic injury [22]. Lingual samples were taken for
istologic analysis at the same time as spleen samples
ere taken for spectratype analysis.
ESULTS
CR CDR3-Size Spectratype Analysis of
lloreactive CD4 T-Cell Populations
In previous studies using the B6 3 BALB.B
iHA-mismatched strain combination, the alloreac-
ive CD8 and CD4 T-cell repertoire responses
ere examined at day 5, early during the onset of
VHD. To investigate the possibility that these re-
ponses might evolve as GVHD progresses, we eval-
ated donor TCR V utilization at several time points
fter transplantation by PCR-based CDR3-size spec-
ratyping of T-cell subsets in the spleen of recipients.
igure 1. Representative CDR3-size spectratype analysis of B6 CD
1 (signiﬁcantly skewed) families were generated from splenic CD4
rom 3 to 5 mice at each time point. The area under each peak is in
isplay increased relative intensities within the spectratype, and th
eparate experiments.o increase the sensitivity of the analysis, donor T m
B&MTells were used from B6 mice that had been presensi-
ized to the BALB.B host miHA antigens. We have
reviously determined that presensitization does not
lter the skewing pattern of the T-cell repertoire [14].
his approach was also critical for obtaining a sufﬁ-
ient level of CD8 T cell–mediated GVHD activity
ithout the addition of CD4 T cells, which seem to
e necessary in the naive donor situation [9].
When host-presensitized B6 CD4 T cells (2.0 
07) were transplanted along with 2  106 ATBM
ells into lethally irradiated (10 Gy) BALB.B recipi-
nts, mice developed the typical signs of GVHD
weight loss, diarrhea, and rufﬂed fur) within 10 to 12
ays. On days 7, 11, 15, 33, and 40, splenic CD4 T
ells were isolated and pooled from 3 to 5 mice, and
DR3-size spectratype analysis was performed. These
xperimental spectratypes were compared with those
f control naive splenic B6 CD4 T-cell spectratypes,
hich were generated from 3 sets of 3 mice each.
In representative spectratypes of an unskewed
D4 V family (V 1), the mean percentage areas
nder each peak of the B6 anti-BALB.B histograms
rom any time point were not signiﬁcantly (P  .05)
reater than their corresponding peaks in the control
pectratype (Figure 1A). In contrast, skewed spectra-
ypes were detected, as in the case of the V 11 family,
n which peak number 4 was signiﬁcantly (P  .05)
kewed at every time point with respect to the corre-
ponding peak in the control spectratype (Figure 1B).
n this way, the V 1 to 16 and 20 families were
nalyzed. The tabulated results were organized ac-
ording to whether V families were consistently,
ransiently, or never skewed over the sampled time
oints. Any V family exhibiting expansion within a
ingle peak at the earliest time point and at least 2
lls. Spectratype histograms of the (A) V 1 (unskewed) and (B) V
lls isolated at days 7, 11,15, 33, and 40 after transplantation pooled
as a percentage of the total histogram. Arrows indicate peaks that
esponding percentage areas are underlined. Data are from 1 of 24 T ce
 T ce
dicated
e corrore subsequent time points was considered to be
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2onsistently skewed. Expansion within a single peak
bserved at any 2 or fewer time points was considered
o be transiently skewed.
The V 6 and 11 families were consistently
kewed at every time point evaluated throughout the
ourse of GVHD, and each response involved expan-
ions within a single peak of their spectratypes (Table
). This pattern strongly suggested that these skewed
 families represented alloreactive responses. To a
esser extent, V 2, 7, 8.1, 10, 13, and 14 were also
onsistently skewed (Table 1). Because previous stud-
es have clearly demonstrated the alloreactive poten-
ial of V 2– and V 11–enriched B6 CD4 T cells
or the induction of lethal GVHD in BALB.B recip-
ents [23], similar relationships may exist among the
ther consistently skewed V families. In further ob-
ervations, V 8.2, 8.3, 9, 15, and 16 exhibited tran-
ient skewing at 1 or 2 time points, whereas V 3 and
2 exhibited skewing at later time points only (Table
). Finally, V 1, 4, 5, and 20 were not skewed at any
ime point during the course of GVHD.
CR CDR3-Size Spectratype Analysis of
lloreactive CD8 T-Cell Populations
In a similar manner to that described previously

able 1. Summary of Spectratype Analysis of CD4 T Cells from Con
Peak
V 2
1 2 3 4 5 6
ay 7      
ay 11      
ay 15      
ay 33      ND
ay 40      
V 6
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 7
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 8.1
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
indicates that the mean area under the peak was signiﬁcantly ske
no skewing; ND, not determined.
Combined results from 2 sets of experimental groups, each analyzor the CD4 T cell–mediated GVHD model, host- b
28resensitized B6 CD8 T cells (2  107) were trans-
lanted along with 2  106 ATBM into lethally irra-
iated (10 Gy) BALB.B recipients. On days 7, 12, 25,
nd 40, splenic CD8 T cells were isolated from 3 to
mice, the samples were pooled, and spectratype
nalysis was performed.
Representative spectratypes of an unskewed V
amily (V 2) indicated that the mean percentage area
nder each peak of the B6 anti-BALB.B histograms
as not signiﬁcantly (P  .05) greater than that of the
orresponding peak in the control spectratype (Figure
A). In contrast, skewed spectratypes were detected, as
epresented by the V 16 family, in which peak 4 is
igniﬁcantly (P  .05) skewed at all time points with
espect to the corresponding peak in the control spec-
ratype. As in the case of the CD4 spectratype analysis
escribed previously, all V family histogram peaks
ere also numbered 1 to 6 from the shorter to the
onger product sizes within the respective spectratype,
nd skewing was similarly deﬁned. In this way, V 1 to
6, 18, and 20 families were analyzed. The results
ndicated that the V 8.2, 14, and 16 families were
onsistently skewed within a single peak at every time
oint evaluated throughout the course of GVHD (Ta-
Skewed V Families*
eak
V 10
1 2 3 4 5 6
ay 7      
ay 11 ND     
ay 15      
ay 33      
ay 40 ND ND    
V 11
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 13
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 14
ay 7      
ay 11      
ay 15      
ay 33      
ay 40 ND     
er that of the normal B6 control for the respective V family; ,
pooled CD4 T cells from 3 to 5 mice at every time point.sistently
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Bere consistently skewed at 3 of the 4 time points
Table 3). Transplanted V 14–enriched B6 CD8 T
ells were previously found to be potent mediators of
ethal GVHD in BALB.B recipients [16], again sup-
orting the relationship between alloreactive potential
nd consistent skewing patterns during the posttrans-
able 2. Summary of Spectratype Analysis of CD4 T Cells from Late
Peak
V 3
1 2 3 4 5 6
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 8.2
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 8.3
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
V 9
ay 7      
ay 11      
ay 15      
ay 33      
ay 40      
indicates that the mean area under the peak was signiﬁcantly ske
no skewing; ND, not determined.
Combined results from 2 sets of experimental groups, each analyz
igure 2. Representative CDR3-size spectratype analysis of B6 CD
6 (signiﬁcantly skewed) families were generated from splenic CD8
to 5 mice at each time point. The area under each peak is indicated
ncreased relative intensities within the spectratype, and the corres
xperiments.
B&MTlantation period. Furthermore, the V 1, 3, 4 to 7,
.1, 9 to 11, and 18 families exhibited transient skew-
ng within a single peak at 2 or fewer time points,
hereas V 20 exhibited skewing at later time points
Table 4). Finally, the V 2 and 15 families were not
kewed at any time point during the course of GVHD.
or Transiently Skewed V Families*
eak
V 12
1 2 3 4 5 6
y 7 ND     
y 11      
y 15 ND     ND
y 33 ND     
y 40 ND     
V 15
y 7      
y 11      
y 15      ND
y 33      
y 40      
V 16
y 7      
y 11      
y 15      
y 33      
y 40      
er that of the normal B6 control for the respective V family; ,
pooled CD4 T cells from 3 to 5 mice at every time point.
lls. Spectratype histograms of the (A) V 2 (unskewed) and (B) V
s isolated at days 7, 12, 25, and 40 after transplantation pooled from
ercentage of the total histogram. Arrows indicate peaks that display
g percentage areas are underlined. Data are from 1 of 2 separate-Onset
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2istologic Evaluation of Lingual Tissue during
VHD Induced by Infiltrating CD4 and CD8
Cells
Sequential analysis of dorsal lingual epithelium as
reviously documented [24-26] disclosed evidence of
rogressive GVHD during the course of the study
Figure 3). These alterations consisted of progressive
ymphoid inﬁltration and epithelial apoptosis selec-
ively involving rete ridge–like prominences. The ex-
ent of inﬁltration and epithelial injury tended to be
reater for CD4-mediated, versus CD8-mediated, dis-
ase for all time points evaluated.
CR CDR3-Size Spectratype Analysis after
epletion of CD4 T-Cell V Families
As described previously, within the CD4 T-cell
opulation, a number of V families exhibited consis-
ent CDR3-size skewings at every time point evalu-
ted (Table 1). Hypothetically, early T-cell responses
ould “dominate” other T-cell responses and delay
heir outgrowth. However, the tissue damage medi-
ted by the early responses might contribute to the
vailability and processing or presentation of other
otential miHA epitopes that could then induce a
econd wave of T-cell responses. Accordingly, to de-
ermine whether the responses observed within these
 families affected the expansions of the transient
nd late-onset skewed V families, the CD4 V
amilies exhibiting consistent or early skewing (V 2,
, 7, 8, 10, 11, 13, and 14) were depleted from the
onor inoculum, and the remaining host-presensitized
6 CD4 V T cells were transplanted at the cell-
quivalent dose (1.48  107) along with 2  106
able 3. Summary of Spectratype Analysis of CD8 T Cells from Con
Peak
V 8.2
1 2 3 4 5 6
ay 7      
ay 12      
ay 25      
ay 40      
V 8.3
ay 7      
ay 12      
ay 25      
ay 40      
V 12
ay 7 ND     ND
ay 12      
ay 25      
ay 40      ND
indicates that the mean area under the peak was signiﬁcantly ske
no skewing; ND, not determined.
Combined results from 2 sets of experimental groups, each analyzTBM into lethally irradiated (10 Gy) BALB.B recip-
30ents. It should be noted that the entire V 8 family
as depleted, and this included the transiently skewed
.2 and 8.3 subfamilies. To demonstrate that the de-
letion process did not affect the functional potential
f the transplanted remaining V families, 5  106
D4 T cells from the selected population were also
ransplanted into lethally irradiated (13 Gy; split dose)
3H (H2k) MHC-mismatched recipients, where they
eadily induced symptoms of GVHD with a signiﬁ-
ant weight loss of 20% (P  .02) by day 23 (data not
hown). For the BALB.B recipients, on days 7, 11, 15,
3, and 40, splenic CD4 T cells were isolated from 3
o 5 mice at each time point, the samples were pooled,
nd spectratype analysis was performed for the re-
aining nonselected V families. As summarized in
igure 4, the results revealed 3 different outcomes.
irst, as indicated with the V 1 and 4 families, there
as no change in their lack of responsiveness, on the
asis of the spectratype analysis. Second, the previ-
usly denoted late-onset or transiently skewed V 3,
, 12, and 16 families (Table 2) each exhibited a delay
n their appearance (Figure 4), in comparison to when
hey were injected with the entire CD4 repertoire.
his result was consistent with the possibility that
VHD-related target tissue injury might enhance the
esponse to less accessible miHA determinants. Third,
he V 15 family exhibited a signiﬁcant shift from a
ate- to an earlier-onset skewing, and the V 5 family
ow displayed transient skewing that was not evident
hen the entire CD4 T-cell population was trans-
lanted into the recipients. Both of these observations
ere consistent with the concept of immunodomi-
ance: ie, in the absence of the strongly reactive donor
Skewed V Families*
Peak
V 13
1 2 3 4 5 6
ay 7      
ay 12 ND     
ay 25 ND     
ay 40      
V 14
ay 7      
ay 12      
ay 25      
ay 40      
V 16
ay 7      ND
ay 12      
ay 25      
ay 40      ND
er that of the normal B6 control for the respective V family; ,
pooled CD8 T cells from 3 to 5 mice at every time point.sistently
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CD4 and CD8 TCR V Repertoires during GVHD
B CD4 T cells, weaker responses have the oppor-
unity to develop.
NA Sequence Analysis
To assess the degree of heterogeneity within a
kewed V family, cDNA was prepared from BALB.B
ecipients transplanted with host-presensitized B6
D4 or CD8 T cells and ampliﬁed by using prim-
rs for V 11 or V 14, respectively. These particular
 families were chosen for sequence analysis because
hey were representative of consistent V skewing and
ave been shown to cause lethal GVHD when trans-
lanted into BALB.B recipients [16,23]. They there-
ore are likely to be responding to disease-relevant
ost miHA. The skewed bands from the V 11
D4 and the V 14 CD8 spectratypes were ex-
ised from the sequencing gels, and sequence analysis
able 4. Summary of Spectratype Analysis of CD8 T Cells from Late
Peak
V 1
1 2 3 4 5 6
ay 7      
ay 12      
ay 25      
ay 40      
V 3
ay 7      
ay 12      ND
ay 25      
ay 40      
V 4
ay 7      
ay 12      
ay 25      
ay 40      
V 5
ay 7      ND
ay 12      
ay 25      ND
ay 40      
V 6
ay 7      
ay 12      
ay 25      
ay 40      
V 7
ay 7      
ay 12      
ay 25      
ay 40      
indicates that the mean area under the peak was signiﬁcantly ske
no skewing; ND, not determined.
Combined results from 2 sets of experimental groups, each analyzas performed. The results indicated that 64% of the C
B&MT1 V 11 CD4 clones sequenced used TCR J 2.5
Table 5) and that 100% of the 27 V 14 CD8
lones sequenced used TCR J 2.4 (Table 6). This
referential J utilization strongly suggested that
here is a dominant alloreactive expansion within the
6 V 11 CD4 and V 14 CD8 T-cell families.
ISCUSSION
Acute GVHD is a multiorgan disease that devel-
ps after allogeneic HCT [1]. The effector phase of
VHD is mediated by mature donor alloreactive T
ells within the hematopoietic stem cell transplant
noculum [4,27] or is a consequence of delayed donor
ymphocyte infusion to counteract leukemic relapse
28]. In the case of MHC-matched transplants,
VHD is initiated when immunocompetent donor
 
or Transiently Skewed V Families*
ak
V 8.1
1 2 3 4 5 6
y 7      
y 12      
y 25      
y 40      
V 9
y 7 ND     
y 12 ND ND    
y 25      
y 40      
V 10
y 7      
y 12      
y 25      
y 40      
V 11
y 7      
y 12      
y 25      
y 40      
V 18
y 7      
y 12 ND ND ND   ND
y 25 No spectratype
y 40      
V 20
y 7      
y 12      
y 25      
y 40      
er that of the normal B6 control for the respective V family; ,
pooled CD8 T cells from 3 to 5 mice at every time point.-Onset
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2ontext of MHC class II and I molecules, respectively,
xpressed on antigen-presenting cells in the peripheral
ymphoid system of the host. The immunopathology
f GVHD has also been well characterized and in-
olves T-cell inﬁltration of target tissues and the sub-
equent activity of alloreactive effector functions that
ead to host cell injury, either directly or indirectly.
ytotoxic activity of effector T cells [29-31] in con-
unction with cytokine production [32] is an important
echanism implicated in organ damage. Tissues such
s the skin, gastrointestinal tract, liver, and lymphoid
rgans are the primary targets of GVHD, and this can
esult in clinical manifestations that include alopecia,
eight loss, scleroderma-like changes, hepatic dys-
unction, diarrhea, and, ultimately, death [1,2]. How-
ver, despite our current appreciation for these events,
he precise nature of several aspects of GVHD immu-
opathologic development remains obscure. These
spects include how T cells speciﬁcally respond to
lloantigens, particularly to multiple miHA; how tis-
ue injury is actually mediated in varying target or-
ans; and how this response evolves over time. One
pproach toward a better understanding of the
igure 3. Sequential histologic conﬁrmation of acute GVHD in lin
33-40 days after BMT). Note the progressive lymphoid inﬁltrati
poptotic epithelial cells (400 original magniﬁcation).VHD response over time is to monitor the T-cell t
32epertoire by CDR3-size spectratyping, thereby per-
itting the determination of which V families are
nvolved in the recognition of host miHA at varying
tages of disease.
TCR CDR3-size spectratyping was used previ-
usly to examine the repertoire of expanding alloreac-
ive CD4 and CD8 T cells early after bone marrow
ransplantation (day 5-6) [14,16]. In this study, we
ddressed whether there were any changes in the re-
ponding T-cell repertoire as GVHD progressed.
erhaps the most signiﬁcant observation in this study
as that the V families in both the CD4 and CD8
-cell subsets exhibited late-onset skewing (Tables 2
nd 4), thus supporting the notion of the synergistic
ffects of increasing tissue damage, whereby early in-
ury could lead to the increased presentation and/or
rocessing of miHA epitopes that otherwise may not
ave elicited a strong T-cell response. This phenom-
non of “epitope spreading” has been well character-
zed in a number of mouse models of autoimmunity,
uch as experimental allergic encephalomyelitis
33,34], nonobese diabetes [35,36], systemic lupus er-
thematosus [37], and chronic organ allograft rejec-
sue at T1 (7 days after BMT), T2 (12-15 days after BMT), and T3
etelike prominences by lymphocytes (arrows) in association withgual tis
on of rion [38]. In addition, T cell–induced tissue damage
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Botentially could lead to presentation of cryptic
pitopes—epitopes that would not be naturally pro-
essed and presented in undamaged tissue [39].
Alternatively, the ﬂuctuations of the CDR3-size
kewing of the T-cell subsets could be a reﬂection of
he increased processing, frequency, and presentation
f miHA as GVHD progresses in conjunction with
he constant trafﬁcking of T cells through the splenic
ymphoid compartment. Increased presentation of
ome epitopes over others could lead to differential
ntigen density, resulting in the immunodominance of
ome V families over others and the corresponding
elay in skewing of the subdominant T-cell V fam-
lies. Additionally, a lower precursor frequency to the
ognate antigens recognized by some T cells within
igure 4. Schematic representation of the change in skewing pattern
VT) or a CD4 T-cell transplant depleted of consistently ske
epresented by elevated symbols at each time point. Except in the
otal CD4 T cells, CDR3-size skewing within each V family wa
able 5. Amino Acid Sequence Analysis of the CDR3 Region from the
kewed Band of CD4 V 11 T Cells
V D J C
2.5
CASS PGLQ DTQYFGPGTRLLVL EDLRNV
CASS PGLQ DTQYFGPGTRLLVL EDLRNV
CASS PGLQ DTQYFGPGTRLLVL EDLRNV
CASS PGLQ DTQYFGPGTRLLVL EDLRNV
CASS FNRG DTQYFGPGTRLLVL EDLRNV
CASS FXRG DTQYFGPGTRLLVL EDLRNV
CASS LVGQ DTQYFGPGTRLLVL EDLRNV
2.6
CASS PSGT GKQYFGPGTRLTVL EDLRNV
CASS SSGT GKQYFGPGTRLTVL EDLRNV
CASS PGTG YEQYFGPGTRLTVL EDLRNV
2.4
CASS LDRD DTLYFGAGTRLSVL EDLRNVB&MThe V families could also account for the later-onset
kewing of those T-cell families. In either case, the
limination of consistently skewed V families might
ed between recipient mice receiving a total CD4T-cell transplant
families (V sel). Skewed spectratypes within a V family are
V 5, for which no skewing was observed after transplantation of
n the same peak.
able 6. Amino Acid Sequence Analysis of the CDR3 Region from the
kewed Band of CD8 V 14 T Cells
V D J C
2.4
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGRQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGRQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGRQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGSSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGSSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGLGFSQ NTLYFGAGTRLSVL EDLRNV
CAWS PGLGVSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGLGVSQ NTLYFGAGTRLSVL EDLRNV
CAWS RGTGASQ NTLYFGAGTRLSVL EDLRNV
CAWS RGTGSSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGLGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS LGLGGAQ NTLYFGAGTRLSVL EDLRNV
CAWS XGTGGAQ NTLYFGAGTRLSVL EDLRNV
CAWS LGTGGSQ NTLYFGAGTRLSVL EDLRNV
CAWS PGTGASQ NTLYFGAGTRLSVL EDLRNV
CAWS LGIGSSQ NTLYFGAGTRLSVL EDLRNV
CAWS QGAGASQ NTLYFGAGTRLSVL EDLRNV
CAWS LVWGSSQ NTLYFGAGTRLSVL EDLRNVobserv
wed V
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2avor increased expansion of late-onset V families,
esulting in early-onset skewing, which could be rel-
vant to the earlier skewing of the V 15 family and
he new skewing of V 5. Finally, it is also possible
hat some of the transiently skewed V families, such
s V 8.2, 8.3, 9, and 16 in the CD4 subset and V 3,
to 8.1, 9, and 18 in the CD8 subset, may not
epresent alloreactive expansions, but rather transient
mmune responses generated against opportunistic
athogens in the recipient mice.
The more delayed skewing of the CD4 V 3, 9,
2, and 16 families when consistently skewed V fam-
lies were removed from the donor inoculum (Figure
) lends support to the notion that the earlier and
tronger T-cell responses may contribute to the re-
ponses of the late-onset V families. Yet it is clear
hat the early responses are not absolutely required,
ecause the late responses do still appear, albeit a week
ater, suggesting that weaker anti-miHA responses can
till develop. The results of the spectratype analysis
uggest the possibility that during the development of
VHD, the alloreactive T cells deﬁned within the V
amilies may interact in a synergistic fashion, either
hrough cytokine production or via direct tissue dam-
ge and release of antigens.
In addition to mediating GVHD, donor T cells
ave also been shown to play a role in promoting
llogeneic stem cell engraftment, in preventing op-
ortunistic infections, and in counteracting leukemic
elapse [40-42]. The long-term survival of HCT re-
ipients is largely dependent on the ability to balance
he positive and negative roles that donor T cells play
n the posttransplantation period. Thus, a better un-
erstanding regarding the particular T cells involved
n these opposing processes could help to facilitate the
eparation of GVHD and graft-versus-leukemia ef-
ects. To this end, the identiﬁcation of the TCR spec-
ﬁcities involved in GVHD would be extremely im-
ortant. Sequence analysis of the TCR-CDR3 region
f the V 11 and V 14 families in the CD4 and CD8
ubsets, respectively, indicated dominant oligoclonal
esponses. The observation that both of these V
amilies were consistently skewed, with respect to
heir appropriate T-cell subset (Tables 1 and 3),
hroughout the time course studied and the fact that
n transplantation into irradiated animals they were
lso able to mediate severe lethal GVHD [16,23] sug-
est that their cognate miHA may be ubiquitously
xpressed. Additionally, their cognate miHA may be
xpressed at a higher level in tissues that are more
ritical for immunopathologic injury associated with
ncreased morbidity and mortality, such as the intes-
inal tract. Further repertoire spectratype analysis of
he target tissue inﬁltrating T lymphocytes should
rovide evidence to support this hypothesis, and stud-
es of this nature are presently under way.It is apparent from this analysis of the donor T-
34ell repertoire during the development of GVHD that
ot all reactive CD4 and CD8 T cells, deﬁned by
 family association, have the same potential for
ediating disease. Further characterization of these
ifferential responses will be important for under-
tanding the immunopathologic progression of
VHD.
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